Building on these results, we evaluated the impact of CuO NPs on the development and exacerbation of asthma, with a particular emphasis on a novel pathway, the TXNIP/ASK1 pathway, which has not been explored in previous studies on respiratory toxicity induced by exposure to CuO NPs, providing a new perspective on targeted signaling strategies. This evidence concerns the gene MAP3K5 and asthma.